| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Aug 15, 2025 | Sale | $48.58 | 2,813 | 136,656 | 103,901 | Aug 19, 2025, 04:30 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Aug 15, 2025 | Option/RSU Exercise | $25.69 | 2,813 | 72,266 | 106,714 | Aug 19, 2025, 04:30 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | May 15, 2025 | Option/RSU Exercise | $25.69 | 1,929 | 49,556 | 105,830 | May 19, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | May 15, 2025 | Sale | $46.18 | 1,929 | 89,081 | 103,901 | May 19, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | May 16, 2025 | Option/RSU Exercise | $25.69 | 883 | 22,684 | 104,784 | May 19, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | May 16, 2025 | Sale | $46.02 | 883 | 40,636 | 103,901 | May 19, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 12, 2025 | Sale | $53.30 | 15,521 | 827,233 | 103,901 | Mar 14, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 12, 2025 | Option/RSU Exercise | $33.02 | 15,521 | 512,503 | 117,027 | Mar 14, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 10, 2025 | Option/RSU Exercise | $31.81 | 68,039 | 2,164,193 | 149,293 | Mar 12, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 10, 2025 | Sale | $53.09 | 68,039 | 3,611,982 | 111,663 | Mar 12, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 11, 2025 | Option/RSU Exercise | $33.02 | 7,381 | 243,721 | 109,563 | Mar 12, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Mar 11, 2025 | Sale | $53.02 | 7,381 | 391,323 | 103,901 | Mar 12, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Feb 19, 2025 | Sale | $50.10 | 1,333 | 66,778 | 105,515 | Feb 21, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Feb 20, 2025 | Sale | $50.12 | 1,614 | 80,900 | 103,901 | Feb 21, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 07, 2025 | Sale | $45.34 | 1,543 | 69,960 | 108,846 | Jan 10, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 08, 2025 | Sale | $44.50 | 1,998 | 88,911 | 106,848 | Jan 10, 2025, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Dec 03, 2024 | Sale | $53.26 | 10,308 | 549,055 | 93,794 | Dec 04, 2024, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Dec 02, 2024 | Option/RSU Exercise | $51.00 | 85,600 | 4,365,600 | 176,029 | Dec 04, 2024, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Dec 02, 2024 | Sale | $52.26 | 85,600 | 4,473,279 | 92,389 | Dec 04, 2024, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Dec 03, 2024 | Option/RSU Exercise | $33.02 | 10,308 | 340,370 | 100,109 | Dec 04, 2024, 05:20 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 30, 2024 | Sale | $27.25 | 794 | 21,637 | 71,189 | Feb 01, 2024, 04:17 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 09, 2024 | Sale | $29.01 | 1,938 | 56,231 | 71,983 | Jan 10, 2024, 04:04 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 08, 2024 | Sale | $28.64 | 1,457 | 41,729 | 73,921 | Jan 10, 2024, 04:04 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 17, 2023 | Option/RSU Exercise | $30.86 | 61,923 | 1,910,944 | 134,009 | Apr 19, 2023, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 17, 2023 | Sale | $51.42 | 61,923 | 3,183,830 | 75,378 | Apr 19, 2023, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 31, 2023 | Sale | $45.63 | 812 | 37,050 | 75,378 | Feb 02, 2023, 04:18 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 11, 2023 | Sale | $44.36 | 495 | 21,958 | 76,190 | Jan 12, 2023, 04:38 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 10, 2023 | Sale | $42.93 | 590 | 25,330 | 76,685 | Jan 12, 2023, 04:38 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Jan 09, 2023 | Sale | $41.66 | 835 | 34,783 | 77,275 | Jan 11, 2023, 06:14 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Oct 17, 2022 | Option/RSU Exercise | $30.86 | 6,602 | 203,738 | 67,512 | Oct 19, 2022, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Oct 17, 2022 | Sale | $55.00 | 6,602 | 363,110 | 61,110 | Oct 19, 2022, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Oct 18, 2022 | Option/RSU Exercise | $30.86 | 299 | 9,227 | 61,399 | Oct 19, 2022, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Oct 18, 2022 | Sale | $55.06 | 299 | 16,462 | 61,110 | Oct 19, 2022, 04:09 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Sep 20, 2022 | Option/RSU Exercise | $30.86 | 1,176 | 36,291 | 61,986 | Sep 22, 2022, 04:38 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Sep 20, 2022 | Sale | $55.00 | 1,176 | 64,680 | 61,110 | Sep 22, 2022, 04:38 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 13, 2022 | Option/RSU Exercise | $11.23 | 2,276 | 25,559 | 63,386 | Apr 15, 2022, 04:02 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 13, 2022 | Sale | $45.17 | 2,276 | 102,811 | 61,110 | Apr 15, 2022, 04:02 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 05, 2022 | Sale | $45.00 | 5 | 225 | 61,110 | Apr 07, 2022, 04:03 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | EXEC. VP AND CLO | Apr 05, 2022 | Option/RSU Exercise | $11.23 | 5 | 56 | 61,115 | Apr 07, 2022, 04:03 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Feb 10, 2022 | Option/RSU Exercise | $17.15 | 17,935 | 307,537 | 76,763 | Feb 11, 2022, 04:11 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Feb 10, 2022 | Sale | $45.03 | 17,935 | 807,559 | 61,110 | Feb 11, 2022, 04:11 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Feb 01, 2022 | Sale | $40.00 | 779 | 31,162 | 61,110 | Feb 03, 2022, 04:57 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jan 07, 2022 | Sale | $38.53 | 885 | 34,095 | 47,489 | Jan 11, 2022, 04:19 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Sep 02, 2021 | Option/RSU Exercise | $18.01 | 3,363 | 60,568 | 51,737 | Sep 03, 2021, 04:06 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Sep 02, 2021 | Sale | $45.01 | 3,363 | 151,375 | 48,374 | Sep 03, 2021, 04:06 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 08, 2021 | Option/RSU Exercise | $16.27 | 7,805 | 127,008 | 50,174 | Jul 12, 2021, 04:26 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 08, 2021 | Sale | $45.22 | 7,805 | 352,968 | 48,374 | Jul 12, 2021, 04:26 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 09, 2021 | Option/RSU Exercise | $18.01 | 1,429 | 25,736 | 48,922 | Jul 12, 2021, 04:26 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 09, 2021 | Sale | $45.00 | 1,429 | 64,306 | 48,374 | Jul 12, 2021, 04:26 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Feb 01, 2021 | Sale | $56.96 | 778 | 44,312 | 48,374 | Feb 02, 2021, 06:23 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jan 05, 2021 | Sale | $62.37 | 772 | 48,150 | 38,952 | Jan 07, 2021, 05:05 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 07, 2020 | Option/RSU Exercise | $15.10 | 30,625 | 462,569 | 57,224 | Jul 09, 2020, 04:08 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 07, 2020 | Sale | $55.12 | 30,625 | 1,688,037 | 56,624 | Jul 09, 2020, 04:08 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 05, 2019 | Sale | $44.74 | 15,312 | 685,097 | 30,965 | Jul 09, 2019, 04:54 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 05, 2019 | Option/RSU Exercise | $15.10 | 15,312 | 231,279 | 33,899 | Jul 09, 2019, 04:54 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jun 28, 2019 | Option/RSU Exercise | $11.35 | 77,575 | 880,723 | 73,614 | Jul 02, 2019, 06:46 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jun 28, 2019 | Sale | $45.00 | 77,575 | 3,490,875 | 29,524 | Jul 02, 2019, 06:46 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 01, 2019 | Option/RSU Exercise | $24.23 | 104,092 | 2,521,639 | 100,373 | Jul 02, 2019, 06:46 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Jul 01, 2019 | Sale | $45.00 | 104,092 | 4,684,140 | 29,524 | Jul 02, 2019, 06:46 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec VP and CLO | Jun 08, 2015 | Option/RSU Exercise | $10.85 | 62,083 | 673,601 | 73,176 | Jun 10, 2015, 06:01 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec VP and CLO | Jun 08, 2015 | Sale | $55.04 | 56,849 | 3,128,737 | 62,400 | Jun 10, 2015, 06:01 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Mar 20, 2015 | Sale | $68.12 | 21,142 | 1,440,247 | 18,782 | Mar 23, 2015, 06:03 PM | |
| PTCT | PTC THERAPEUTICS, INC. | Mark Elliott Boulding | Exec. VP and CLO | Mar 20, 2014 | Sale | $30.96 | 10,049 | 311,117 | 32,235 | Mar 21, 2014, 04:46 PM |